AzTrials
AzTrials

Adolescent BehaviorNCT04875546

An Integrated Smoking Cessation and Alcohol Intervention Among Hong Kong Chinese Young People

A study testing Standard treatment and Integrated Intervention in people with Adolescent Behavior, run by The Hong Kong Polytechnic University at 1 site in Hong Kong.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Current smoking cessation interventions are focused only on smoking behaviors, and drinking habits are generally overlooked. The aims of the project is to examine the feasibility of implementing an integrated smoking cessation and alcohol abstinence intervention in young Hong Kong Chinese smokers. Read more about this study

Who is it for?
Ages 18 to 25 yearsHealthy volunteers can take part
Conditions the study is for
Adolescent Behavior
What is being tested?
Standard treatment and Integrated Intervention
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
150 participants
Where
1 siteHong Kong
Study dates
1 Jul 2022to 1 Jul 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 25 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • smoked at least one cigarette in the past 30 days.
  • have consumed at least one cup of alcohol in the past 30 days.
  • speak Cantonese

Who cannot join

  • have a compromised mental status and/or communication problems.
  • participating in other smoking cessation interventions

Trial locations and contacts

1 site in 1 country.

Ka Yan Ho, Phd contact

27666417

kyeva.ho@polyu.edu.hk

Hong Kong1 site
  • Ka Yan Ho

    Hong Kong, Hong Kong,China, 0000

Other trials in Hong Kong

About this study

Current smoking cessation interventions are focused only on smoking behaviors, and drinking habits are generally overlooked. The aims of the project is to examine the feasibility of implementing an integrated smoking cessation and alcohol abstinence intervention in young Hong Kong Chinese smokers.

Read the detailed description

The study is a three-arm randomized controlled trial. (1)The standard treatment group , participants will receive a brief smoking cessation intervention based on the '5A' and '5R' model, then the RA will assist the participants to quit smoking using the STAR method. (2) For the alcohol intervention group, participants will also receive a brief smoking cessation intervention with the models as the ST group. After that they will receive a brief advice on alcohol use based on the FRAMES model. Then the RA will invite participants to complete the Alcohol Use Disorders Identification Test(AUDIT). (3) For the Control group, participants will be provide with two leaflets, one for smoking cessation and another for alcohol abstinence. All the data collection will be conducted at baseline, 1 week, 1 month , 3 months and 6 months for follow up.

Being tested
Standard treatment, Integrated Intervention, Control
Keywords
smoking, alcohol, adolescents
Medical subject headings
Adolescent Behavior, Smoking

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Standard treatmentBehavioural

    Adolescent will receive a brief smoking cessation intervention based on the '5A' and '5R' models. Then the research assistant will ask about their tobacco use and assist them to quit using the STAR method. A booster intervention will be given over the phone at 1-week, 1month, 3-month, and 6 month follow-up.

  • Integrated InterventionBehavioural

    In addition to the brief smoking cessation intervention based on the '5A' and '5R' models, the participants will receive brief advice on alcohol use based on the FRAMES model. Then the RA will invite participants to complete the Alcohol Use Disorders Identification Test and provide personalized feedback. There will be a one to one, 20-30 minutes semi-structured interviews with 30 participants. Participants with high(N=15) and low (N=15) adherence will be purposively selected. A booster intervention will be given over the phone at 1-week, 1month, 3-month, and 6 month follow-up.

  • ControlOther

    The adolescents will receive the leaflets for smoking cessation and alcohol abstinence. A booster intervention will be given over the phone at 1-week, 1month, 3-month, and 6 month follow-up.

Study groups in NCT04875546
Study groupRoleWhat they receive
Standard treatmentActive comparator* A 5'A' and '5'R' models * STAR method for quitting
Receives: Behavioral: Standard treatment
Integrated InterventionActive comparator* A 5'A' and '5'R' models * Receive brief advice on alcohol use based on the FRAMES model * Complete the Alcohol Use Disorders Identification Test
Receives: Behavioral: Integrated Intervention
ControlSham comparatorParticipants will receive two leaflets.
Receives: Other: Control

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The biochemical validation

    Measuring the level of carbon monoxide in expired air and level of cotinine in saliva

    Measured: At the 6-month follow-up

  2. Structured questionnaire

    The questionnaire will include six areas: smoking profile, cessation history, readiness to quit, self-efficacy to quit, alcohol use and demographics.

    Measured: At baseline

Secondary outcomes (26)
  1. Randomization rate

    The number of participants who randomized divided by the number of eligible smokers who consent to participate

    Measured: Immediately after the training workshop

  2. Attendance rate

    The number of participants who complete intervention divided by the number of participants who are randomized into the treatment arms participants who are randomized into the treatment arms

    Measured: Immediately after the training workshop

  3. Adherence to intervention at baseline

    The number of participants in the two treatment arms who practice the skills learned during the intervention divided by the number of participants in the two treatment arms during the intervention divided by the number of participants in the two treatment arm.

    Measured: At baseline

  4. Adherence to intervention at 1-week follow-up

    The number of participants in the two treatment arms who practice the skills learned during the intervention divided by the number of participants in the two treatment arms during the intervention divided by the number of participants in the two treatment arm.

    Measured: At 1-week follow-up

  5. Adherence to intervention at 1-month follow-up

    The number of participants in the two treatment arms who practice the skills learned during the intervention divided by the number of participants in the two treatment arms during the intervention divided by the number of participants in the two treatment arm.

    Measured: At 1-month follow-up

  6. Adherence to intervention at 3-month follow-up

    The number of participants in the two treatment arms who practice the skills learned during the intervention divided by the number of participants in the two treatment arms during the intervention divided by the number of participants in the two treatment arm.

    Measured: At 3-month follow-up

  7. Adherence to intervention at 6-month follow-up

    The number of participants in the two treatment arms who practice the skills learned during the intervention divided by the number of participants in the two treatment arms during the intervention divided by the number of participants in the two treatment arm.

    Measured: At 6-month follow-up

  8. Retention rate at baseline

    The number of participants who remain in the study divided by the number of participants randomized. Retention rate will be calculated for each arm at baseline and follow-ups.

    Measured: At baseline

  9. Retention rate at 1-week follow-up

    The number of participants who remain in the study divided by the number of participants randomized. Retention rate will be calculated for each arm at baseline and follow-ups.

    Measured: At 1-week follow-up

  10. Retention rate at 1-month follow-up

    The number of participants who remain in the study divided by the number of participants randomized. Retention rate will be calculated for each arm at baseline and follow-ups.

    Measured: At 1-month follow-up

  11. Retention rate at 3-month follow-up

    The number of participants who remain in the study divided by the number of participants randomized. Retention rate will be calculated for each arm at baseline and follow-ups.

    Measured: At 3-month follow-up

  12. Retention rate at 6 month follow-up

    The number of participants who remain in the study divided by the number of participants randomized. Retention rate will be calculated for each arm at baseline and follow-ups.

    Measured: At 6-month follow-up

  13. Completion rate at baseline

    The number of participants who complete the questionnaire divided by the number of questionnaires distributed.

    Measured: At baseline

  14. Completion rate at 1-week follow-up

    The number of participants who complete the questionnaire divided by the number of questionnaires distributed.

    Measured: At 1-week follow-up

  15. Completion rate at 1-month follow-up

    The number of participants who complete the questionnaire divided by the number of questionnaires distributed.

    Measured: At 1-month follow-up

  16. Completion rate at 3-month follow-up

    The number of participants who complete the questionnaire divided by the number of questionnaires distributed.

    Measured: At 3-month follow-up

  17. Completion rate at 6-month follow-up

    The number of participants who complete the questionnaire divided by the number of questionnaires distributed.

    Measured: At 6-month follow-up

  18. Missing data at baseline

    The percentage of missing data.

    Measured: At baseline

  19. Missing data at 1-week follow-up

    The percentage of missing data.

    Measured: At 1-week follow-up

  20. Missing data at 1-month follow-up

    The percentage of missing data.

    Measured: At 1-month follow-up

  21. Missing data at 3-month follow-up

    The percentage of missing data.

    Measured: At 3-month follow-up

  22. Missing data at 6-month follow-up

    The percentage of missing data.

    Measured: At 6-month follow-up

  23. Adverse events

    Unfavorable or unintended events during the study period that were not present at baseline or appear to have worsened since baseline

    Measured: At the 6 months follow up

  24. Screen rate

    The number of people screened divided by the number of people available for screening.

    Measured: Immediately after the training workshop

  25. Consent rate

    The number of eligible smokers who agree to participate divided by the number of eligible smokers

    Measured: Immediately after the training workshop

  26. Eligibility rate

    The number of eligible smokers divided by the number of screened people.

    Measured: Immediately after the training workshop

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 May 2021
  2. Study start1 Jul 2022 (estimated)
  3. Primary completion1 Jul 2024 (estimated)
  4. Study completion1 Jul 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Factorial
Masking
None (open label)
Enrolment
150 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04875546
Sponsor's protocol ID
Smk_AI-RCT
Status last verified
May 2021
First submitted
20 Apr 2021
Last updated
6 May 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Standard treatment and Integrated Intervention in people with Adolescent Behavior, run by The Hong Kong Polytechnic University at 1 site in Hong Kong.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 6 May 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Ka Yan Ho, Phd (27666417, kyeva.ho@polyu.edu.hk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The biochemical validation (time frame: At the 6-month follow-up). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 May 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in